0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

È£ÈíºÎÀüÀÌ ¹ß»ýÇÑ Ç÷¾×¾ÏȯÀÚÀÇ °íÀ¯·® ºñ°­ ij´¼¶ó »ê¼Ò¿ä¹ýÀÇ ¼º°ø¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ

Factors Influencing the Success of High-flow Nasal Cannula Treatment Applied to Respiratory Distress Patients with Hematologic Neoplasms

Á¾¾ç°£È£¿¬±¸ 2023³â 23±Ç 4È£ p.185 ~ 195
KMID : 1035120230230040185
±èÀºÈñ ( Kim Eun-Hee ) - 

±èµ¿¿¬ ( Kim Dong-Yeon ) - 
À¯¾ç¼÷ ( Yoo Yang-Sook ) - 

Abstract

Purpose: This study aimed to evaluate the respiratory rate oxygenation (ROX) index, ROX-heart rate (ROX-HR) index, and saturation of percutaneous oxygen/fraction of inspired oxygen ratio (SF ratio) to predict the success for high-flow nasal cannula (HFNC) treatment applied to patients with hematologic neoplasms.

Methods: A total of 167 patients who were admitted to the hematology intensive care unit were included in this study. Data were collected from electronic nursing records and were analyzed using the ¥ö2 test, independent t-test, Mann-Whitney U test, logistic regression, Receiver Operating Characteristic curve, and Area Under the Curve (AUC).

Results: Eighty-nine (53.3%) patients were successfully weaned from HFNC, while 78 (46.7%) were unsuccessful. Considering specificity and sensitivity, the optimal cut-off points for predicting the success and failure of HFNC oxygen therapy were 4.50 and 14.16 (ROX index), 3.78 and 15.05 (ROX-HR index), and 119.95 and 278.06 (SF ratio), respectively. Time measurement showed that the most significant AUC was recorded before HFNC interruption occurred.

Conclusion: Nurses caring for critically ill patients with hematologic neoplasms should closely observe and periodically check patients¡¯ breathing patterns. It is crucial to continuously monitor three indexes to ensure that ventilation assistance therapy is started at the right time.
KeyWords
½É¹Úµ¿¼ö, Ç÷¾×¾Ï, ÁßȯÀÚ½Ç, »ê¼ÒÆ÷È­µµ, È£ÈíºÎÀü
Heart rate, Hematologic neoplasms, Intensive care units, Oxygen saturation, Respiratory insufficiency
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸